Ali Warbington

Company: ImmunoGen

Job title: Director - Toxicology

Seminars:

Workshop B: Regulatory Expectations – Testing ADC Toxicity & Designing Experiments in Accordance to Obtain IND and BLA Approval 1:00 pm

With the common goal of developing ADCs with the highest therapeutic index, the industry is gradually shifting away from traditional ADCs and testing methods and towards novel approaches, such as a reduction in animal testing and newer payload and mechanistic technologies. From these advances, a question has to be asked – what are the regulatory…Read more

day: Workshop Day

Looking into Ocular Challenges: Mitigating and Managing ADC Ocular Surface Toxicity 11:30 am

Overview of ocular surface toxicities associated with ADCs Case study: clinical presentation and management of corneal adverse events associated with a maytansine ADC Evaluating preclinical models to evaluate ADC ocular toxicityRead more

day: Conference Day 1